current affair

The CDSCO has also recommended granting approval to Bharat Biotech for conducting an interchangeability study on COVAXIN and adenoviral intranasal vaccine BBV154. Read all you need to know.

from Jagran Josh https://ift.tt/2UVnPQd
via IFTTT